Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2005
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformationXiaohui Lu, Ross Levine, Wei Tong, et al.Cell Stem Cell|June 6, 2009
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesisInga Hofmann, Elizabeth H Stover, Dana E Cullen, et al.Blood|March 26, 2005
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412Joseph D Growney, Jennifer J Clark, Jennifer Adelsperger, et al.Blood|January 26, 2006
X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesisRoss L Levine, Claude Belisle, Martha Wadleigh, et al.British Journal of Haematology|November 17, 2006
Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over timeTerra L Lasho, Animesh Pardanani, Rebecca F McClure, et al.Blood|November 25, 2003
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJan Cools, Hilmar Quentmeier, Brian J P Huntly, et al.Blood|April 22, 2006
Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITDJennifer L Rocnik, Rachel Okabe, Jin-Chen Yu, et al.Cancer Cell|July 19, 2002
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Ellen Weisberg, Christina Boulton, Louise M Kelly, et al.Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.Blood|December 17, 2009
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in miceMichael G Kharas, Rachel Okabe, Jared J Ganis, et al.Pageof 18